Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...

Safe coding is a collection of software design practices and patterns that allow for cost-effectively achieving a high degree ...